Advanced Oncotherapy (LON:AVO) Posts Quarterly Earnings Results, Misses Expectations By $0.93 EPS
Advanced Oncotherapy (LON:AVO) issued its earnings results on Monday. The company reported GBX (9.83) (($0.12)) earnings per share for the quarter, missing the consensus estimate of GBX (8.90) (($0.11)) by GBX (0.93) (($0.01)), Bloomberg Earnings reports.
LON:AVO opened at GBX 26 ($0.32) on Tuesday. The firm has a market cap of $79.66 million and a P/E ratio of -1.86. The company has a current ratio of 2.16, a quick ratio of 0.79 and a debt-to-equity ratio of 55.71. The stock’s 50 day simple moving average is GBX 26.68 and its 200-day simple moving average is GBX 32.10. Advanced Oncotherapy has a 12-month low of GBX 20 ($0.25) and a 12-month high of GBX 44.50 ($0.55).
About Advanced Oncotherapy
See Also: FinTech
Receive News & Ratings for Advanced Oncotherapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Oncotherapy and related companies with MarketBeat.com's FREE daily email newsletter.